ClinicalTrials.gg
Drug

Nonoxynol clinical trials

studies test it
3
open now
0
in phase 3
1
first study started
2012

How each study uses Nonoxynol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
10 Dec 1963 · DELFEN · NDA 014349 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorisations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Nonoxynol-9
3

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
1
Phase 3
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 0 · Other 3

National Institute of Allergy and Infectious Diseases (NIAID) (2) · CONRAD (1)

Often tested with

Tested in the same studies.

Imiquimod (1)

Studies

Open first, then newest update. How each study uses Nonoxynol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 3

Given beside what is tested · 1 — Nonoxynol is usual care or a partner of the new treatment
As the comparator · 5 — what is tested is compared with Nonoxynol

Codes

What other systems call Nonoxynol · ClinicalTrials.gg INT008557

  • MeSH (NLM) D017137NonoxynolOne source ClinicalTrials.gov

Also registered as nonoxynol-10 (UNII K7O76887AP · RxNorm 1311556) and nonoxynol-9 (UNII 48Q180SH9T · RxNorm 53750).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.